Canopy Growth Reports Yet Another Weak Earnings Quarter

Losses widened year-over-year, while net revenue declined 15 percent from the previous quarter, for the world’s highest-valued cannabis company.

Business
Business

Can Harborside Win Its Long Fight With the Feds?

One of the oldest names in cannabis, Harborside has been battling a federal tax bill for years, and the outcome could shape the industry’s future.

Lobbying

Lobbying: GW Pharmaceuticals Extends Its Reach

The company’s subsidiary donates big to attorneys general groups of both parties.

Colorado

In Denver, a Debate Begins Over How to Create an Equitable Cannabis Hospitality Industry

After the first meeting to debate delivery, Denver’s new Marijuana Licensing Work Group, which includes regulators, elected officials, and industry members, turned its attention to consumption spaces.